Interest of modafinil, a new psychostimulant, during a sixty-hour sleep deprivation experiment.

Lagarde D, Batejat D, Van Beers P, Sarafian D, Pradella S.

Institut de Medecine Aerospatiale (Imassa-Cerma), 
Departement Sciences Cognitives et Ergonomie,
 Bretigny-sur-Orge, France.
Fundam Clin Pharmacol 1995;9(3):271-9

ABSTRACT

Modafinil, a new psychostimulant, was evaluated in eight healthy volunteers subjected to 60 hours of sleep deprivation. During continued wakefulness, vigilance was evaluated by self-assessment questionnaires, analogue visual scales, multiple sleep latency tests (MSLT), sleep logs, and continuous ambulatory electroencephalographic recordings (EEG). Modafinil (200 mg) or a placebo was given every 8 hours for three days; the sessions were separated by a 15 day wash out period. Results indicated a satisfactory level of vigilance, both subjective and objective, after the administration of modafinil, characterised by the quasi total absence of microsleep episodes which gradually occurred under placebo conditions. The confirmed wakening potency of modafinil makes this substance suitable for therapeutic use in patients with sleep disorders such as Gelineau's syndrome and hypersomnia.

 1.   Modafinil  for sustaining the alertness of helicopter pilots
 2.   Modafinil  augmentation of antidepressant treatment
 3.   Modafinil  the unique properties of a new stimulant 
 4.   Modafinil  children with attention-deficit/hyperactivity disorder
 5.   Modafinil  dosage and safety
 6.   Modafinil  successful treatment of hypersomnia & narcolepsy
 7.   Modafinil  narcolepsy: symptoms and management
 8.   Modafinil  amplification of cortical serotonin release
 9.   Modafinil  treatment of alcoholic organic brain syndrome
10.  Modafinil  effect on melatonin, cortisol, and growth hormone
11.  Modafinil  in obstructive sleep apnea-hypopnea syndrome
12.  Modafinil  vs dextroamphetamine in treatment of adult ADHD
13.  Modafinil  efficacy in narcolepsy
14.  Modafinil  switching from narcolepsy drugs to modafinil
15.  Modafinil  dopaminergic transmission mediates CNS stimulants

| Home | Order |
www.AlzheimersTreatments.com

 

 

 

 

Hit Counter